Pharmacovigilance and Drug Safety Software Market (By Functionality: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software; By Delivery Mode: On-premise Delivery Mode, On-demand/Cloud based (SaaS) Delivery Mode; By End User: Pharma and Biotech Companies, Contract Research Organizations (CROs), Business Process Outsourcing (BPO) Firms, Other Pharmacovigilance Service Providers) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

CHAPTER 1. Industry Overview of Pharmacovigilance and Drug Safety Software
1.1. Definition and Scope 
1.1.1. Definition of Pharmacovigilance and Drug Safety Software
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Pharmacovigilance and Drug Safety Software Market
1.2. Summary
1.2.1. Executive Summary 
1.2.2. Pharmacovigilance and Drug Safety Software Market By Functionality
1.2.3. Pharmacovigilance and Drug Safety Software Market By Delivery Mode
1.2.4. Pharmacovigilance and Drug Safety Software Market By End User
1.2.5. Pharmacovigilance and Drug Safety Software Market by Regions

CHAPTER 2. Research Approach
2.1. Methodology 
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2 
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Pharmacovigilance and Drug Safety Software Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Pharmacovigilance and Drug Safety Software Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers 
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2. R&D Status and Application Source of Pharmacovigilance and Drug Safety Software Major Manufacturers in 2019

CHAPTER 5. Pharmacovigilance and Drug Safety Software Market By Functionality
5.1. Introduction
5.2. Pharmacovigilance and Drug Safety Software Revenue By Functionality
5.2.1. Pharmacovigilance and Drug Safety Software Revenue (US$ Mn) and Forecast, By Functionality, 2016-2027
5.2.2. Adverse Event Reporting Software
5.2.2.1. Adverse Event Reporting Software Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Drug Safety Audits Software
5.2.3.1. Drug Safety Audits Software Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Issue Tracking Software
5.2.4.1. Issue Tracking Software Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Fully Integrated Software
5.2.5.1. Fully Integrated Software Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 6. Pharmacovigilance and Drug Safety Software Market Revenue By Delivery Mode
6.1. Introduction
6.2. Pharmacovigilance and Drug Safety Software Revenue (US$ Mn) By Delivery Mode
6.2.1. Pharmacovigilance and Drug Safety Software Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 - 2027
6.2.2. On-premise Delivery Mode
6.2.2.1. On-premise Delivery Mode Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. On-demand/Cloud based (SaaS) Delivery Mode
6.2.3.1. On-demand/Cloud based (SaaS) Delivery Mode Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 7. Pharmacovigilance and Drug Safety Software Market By End User 
7.1. Introduction
7.2. Pharmacovigilance and Drug Safety Software Revenue (US$ Mn) By End User
7.2.1. Pharmacovigilance and Drug Safety Software Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
7.2.2. Pharma and Biotech Companies
7.2.2.1. Pharma and Biotech Companies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.3. Contract Research Organizations (CROs)
7.2.3.1. Contract Research Organizations (CROs) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.4. Business Process Outsourcing (BPO) Firms
7.2.4.1. Business Process Outsourcing (BPO) Firms Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.5. Other Pharmacovigilance Service Providers
7.2.5.1. Other Pharmacovigilance Service Providers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 8. North America Pharmacovigilance and Drug Safety Software Market By Country 
8.1. North America Pharmacovigilance and Drug Safety Software Overview
8.2. U.S.
8.2.1. U.S. Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016-2027
8.2.2. U.S. Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016-2027
8.2.3. U.S. Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.3. Canada
8.3.1. Canada Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016-2027
8.3.2. Canada Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016-2027
8.3.3. Canada Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.4. North America PEST Analysis

CHAPTER 9. Europe Pharmacovigilance and Drug Safety Software Market By Country
9.1. Europe Pharmacovigilance and Drug Safety Software Market Overview
9.2. U.K.
9.2.1. U.K. Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016-2027
9.2.2. U.K. Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016-2027
9.2.3. U.K. Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.3. Germany
9.3.1. Germany Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016-2027
9.3.2. Germany Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016-2027
9.3.3. Germany Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.4. France 
9.4.1. France Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016-2027
9.4.2. France Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016-2027
9.4.3. France Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.5. Spain
9.5.1. Spain Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016-2027
9.5.2. Spain Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016-2027
9.5.3. Spain Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016-2027
9.6.2. Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016-2027
9.6.3. Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.7. Europe PEST Analysis

CHAPTER 10. Asia Pacific Pharmacovigilance and Drug Safety Software Market By Country
10.1. Asia Pacific Pharmacovigilance and Drug Safety Software Market Overview
10.2. China
10.2.1. China Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 - 2027
10.2.2. China Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 - 2027
10.2.3. China Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.3. Japan
10.3.1. Japan Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 - 2027
10.3.2. Japan Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 - 2027
10.3.3. Japan Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.4. India
10.4.1. India Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 - 2027
10.4.2. India Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 - 2027
10.4.3. India Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.5. Australia
10.5.1. Australia Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 - 2027
10.5.2. Australia Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 - 2027
10.5.3. Australia Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.6. South Korea
10.6.1. South Korea Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 - 2027
10.6.2. South Korea Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 - 2027
10.6.3. South Korea Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 - 2027
10.7.2. Rest of Asia-Pacific Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 - 2027
10.7.3. Rest of Asia-Pacific Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Pharmacovigilance and Drug Safety Software Market By Country
11.1. Latin America Pharmacovigilance and Drug Safety Software Market Overview
11.2. Brazil
11.2.1. Brazil Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 - 2027
11.2.2. Brazil Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 - 2027
11.2.3. Brazil Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.3. Mexico
11.3.1. Mexico Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 - 2027
11.3.2. Mexico Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 - 2027
11.3.3. Mexico Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 - 2027
11.4.2. Rest of Latin America Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 – 2027
11.4.3. Rest of Latin America Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Pharmacovigilance and Drug Safety Software Market By Country 
12.1. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 - 2027
12.2.2. Saudi Arabia Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 - 2027
12.2.3. Saudi Arabia Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
12.3. UAE
12.3.1. UAE Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 - 2027
12.3.2. UAE Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 - 2027
12.3.3. UAE Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 - 2027
12.4.2. Rest of Middle East & Africa Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 - 2027
12.4.3. Rest of Middle East & Africa Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Pharmacovigilance and Drug Safety Software
13.1. Pharmacovigilance and Drug Safety Software Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Pharmacovigilance and Drug Safety Software Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. COMPANY PROFILE
14.1. ArisGlobal
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. ArisGlobal 2019 Pharmacovigilance and Drug Safety Software Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Ennov
14.3. EXTEDO
14.4. Online Business Applications, Inc.
14.5. Oracle Corporation
14.6. Sarjen Systems Pvt. Ltd
14.7. Sparta Systems, Inc.
14.8. United BioSource LLC
14.9. Others

Cart Summary